Medical device manufacturer
Quidel Corporation
Quidel Corporation holds 128 FDA 510(k) clearances across 36 product codes. Median elapsed review time is 71 days. openFDA lists 15 recall records naming the company. FDA publishes it under 5 different spellings, all counted here as one company.
Updated · ingest status · JSON
- 510(k) clearances
- 128
- Product codes
- 36
- Median review
- 71 days
- Recall records
- 15
How does FDA spell Quidel Corporation?
FDA publishes this company under 5 different spellings across its datasets. Every figure on this page counts all of them as one company, which is why the totals here are higher than a search for any single spelling would give you.
| As FDA published it | Dataset | Matched by |
|---|---|---|
| QUIDEL CORP. | device/registrationlisting | normalised |
| Quidel Corp. | device/510k | normalised |
| Quidel Corporation | device/510k | normalised |
| Quidel Corporation | device/enforcement | normalised |
| Quidel Corporation | device/recall | normalised |
Merges are measured against a hand-labelled sample and held above 98% precision. Pairs the matcher is unsure of are queued for a person rather than merged, because two genuinely different firms with similar names is the error that would corrupt every count on this page.
Which product codes does Quidel Corporation file in?
36 product codes, ranked by how much they file in each.
| Code | Device | Clearances | Median review | Latest |
|---|---|---|---|---|
| JHI | Visual, Pregnancy Hcg, Prescription Use | 20 | 51 days | |
| DHB | System, Test, Radioallergosorbent (Rast) Immunological | 9 | 59 days | |
| LCX | Kit, Test, Pregnancy, Hcg, Over The Counter | 9 | 43 days | |
| GTZ | Antisera, All Groups, Streptococcus Spp. | 8 | 62 days | |
| PSZ | Devices Detecting Influenza A, B, And C Virus Antigens | 8 | 88 days | |
| LYR | Helicobacter Pylori | 6 | 105 days | |
| GTY | Antigens, All Groups, Streptococcus Spp. | 5 | 168 days | |
| JJX | Single (Specified) Analyte Controls (Assayed And Unassayed) | 5 | 48 days | |
| OCC | Respiratory Virus Panel Nucleic Acid Assay System | 5 | 88 days | |
| GQG | Antigen, Cf (Including Cf Controls), Respiratory Syncytial Virus | 4 | 77 days | |
| CEP | Radioimmunoassay, Luteinizing Hormone | 3 | 57 days | |
| DGC | Ige, Antigen, Antiserum, Control | 3 | 60 days | |
| GNX | Antigens, Cf (Including Cf Control), Influenza Virus A, B, C | 3 | 32 days | |
| LJC | Enzyme Linked Immunoabsorbent Assay, (Chlamydiae Group) | 3 | 108 days | |
| LSR | Reagent, Borrelia Serological Reagent | 3 | 290 days | |
| OEM | Human Metapneumovirus (Hmpv) Rna Assay System | 3 | 108 days | |
| OZE | Influenza A And Influenza B Multiplex Nucleic Acid Assay | 3 | 78 days | |
| OZN | C. Difficile Toxin Gene Amplification Assay | 3 | 72 days | |
| PGX | Groups A, C And G Beta-Hemolytic Streptococcus Nucleic Acid Amplification System | 3 | 79 days | |
| KTN | System, Test, Infectious Mononucleosis | 2 | 30 days | |
| NJR | Nucleic Acid Amplification Assay System, Group B Streptococcus, Direct Specimen Test | 2 | 36 days | |
| OUY | Trichomonas Vaginalis Nucleic Acid Amplification Test System | 2 | 110 days | |
| OZZ | Bordetella Pertussis Dna Assay System | 2 | 33 days | |
| PGI | Herpes Virus (Vzv, Hsv1, Hsv2), Dna Detection Assay For Cutaneous And Mucocutaneous Lesion Samples | 2 | 88 days | |
| CEN | Dye-Indicator, Ph (Urinary, Non-Quantitative) | 1 | 118 days |
Showing the 25 they file in most, of 36.
Median review is elapsed calendar days between date received and decision date, as published by FDA. It is not FDA review days — the two differ whenever the agency stops the clock for an additional information request.
Source: openFDA device/510k · retrieved
Has Quidel Corporation had a recall?
openFDA lists 15 recall records naming this company across its whole history, of which 1 was opened in the last 12 months and is not yet marked terminated. A recall record covers one firm's corrective action and may span many device lots.
Z-2169-2026Class IIOpen, ClassifiedGTY
Product has the potential for false positive results
Z-2545-2025Class IIOpen, ClassifiedGTY
Dipstick strep A test has potential for false positive results.
Z-1636-2024Class IIOpen, ClassifiedPFQ
There are two windows on the test device, the control line window and the test results window. The line for the test results window were misaligned. In instances of positive test results, the positivite test line may not be visible/ hidden under the cassette of the test device thus potentially leading to a false negative result.
Z-1637-2024Class IIOpen, ClassifiedPFQ
There are two windows on the test device, the control line window and the test results window. The line for the test results window were misaligned. In instances of positive test results, the positivite test line may not be visible/ hidden under the cassette of the test device thus potentially leading to a false negative result.
Z-1086-2024Class IIOpen, ClassifiedQMN
One lot of the Sofia 2 Flu + SARS Antigen FIA (Lot 709083) was labelled with incorrect expiration dates. The kits contain pouched cassettes labeled with an expiration date of May 31, 2025, however the correct expiration date for the pouches is September 12, 2024. The kits are labeled with an expiration date of April 30, 2025, however, the correct expiration date for the kits is September 12, 2024. The issue was discovered on November 28, 2023 by a supply chain employee who determined that the kits had expiration dates beyond the FDA authorized shelf life.
Showing the 5 most recently initiated of 15.
Recall class comes from openFDA's enforcement endpoint, which does not carry every recall — where it is missing, none is shown rather than guessed. Recall class I is the most serious kind of recall; device class I is the least risky kind of device, and the two are never mixed here.
Source: openFDA device/recall · retrieved
What has Quidel Corporation cleared recently?
| 510(k) | Device | Code | Decision | Elapsed days |
|---|---|---|---|---|
| K231795 | QuickVue COVID-19 Test | QYT | 276 | |
| K232286 | Savanna HSV 1+2/VZV Assay, Savanna HSV 1+2/VZV Control Set, Savanna Instrument | PGI | 141 | |
| K233688 | Sofia 2 SARS Antigen+ FIA; Sofia 2 SARS Antigen+ FIA Control Swab Set | QVF | 26 | |
| K230349 | Lyra RSV+hMPV Assay | OEM | 29 | |
| K230236 | Lyra Influenza A+B Assay | OZE | 32 | |
| K211342 | Sofia 2 Campylobacter FIA | LQP | 204 | |
| K173496 | Sofia 2 Lyme FIA, Sofia Lyme Control Set | LSR | 290 | |
| K181029 | Solana Bordetella Complete Assay | OZZ | 88 | |
| K173691 | Sofia Lyme FIA, Sofia 2 analyzer, Sofia 2 Installation Pack | LSR | 89 | |
| K180288 | QuickVue Influenza A+B | PSZ | 12 |
Source: openFDA device/510k · retrieved
Where is Quidel Corporation registered?
FDA lists 1 registered establishment for this company in US.
Registration means the firm has told FDA it makes or distributes devices from that site. It is not a clearance, an approval or an endorsement.
Watch what Quidel Corporation files next
Get an email when this company clears a new device, or when anything is recalled in a product code you follow.
Data on this page comes from FDA's public openFDA API and is US public domain (CC0). DeviceSignal is an independent commercial service and is not affiliated with the U.S. Food and Drug Administration. Information only, not regulatory advice. Verify anything you rely on against open.fda.gov.